Evidence map›Paper›PMID 38786765›Full record

ArticleMetabolites2024

Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus.

Ahalya Anita Suntharalingam Kvist, Archana Sharma, Christine Sommer, Elisabeth Qvigstad, Hanne Løvdal Gulseth, Stina Therese Sollid, Ingrid Nermoen, Naveed Sattar, Jason Gill, Tone Møller Tannæs and 2 more

Abstract read
In one paragraph

Article in Metabolites, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahalya Anita Suntharalingam KvistInstitute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Archana SharmaInstitute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Christine SommerDepartment of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, 0424 Oslo, Norway.
Elisabeth QvigstadInstitute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Hanne Løvdal GulsethNorwegian Institute of Public Health, 0213 Oslo, Norway.
Stina Therese SollidDepartment of Medicine, Drammen Hospital, Vestre Viken Health Trust, 3004 Drammen, Norway.
Ingrid NermoenInstitute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Naveed SattarSchool of Cardiovascular and Metabolic Health, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK.
Jason GillSchool of Cardiovascular and Metabolic Health, University of Glasgow, BHF Glasgow Cardiovascular Research Centre, 126 University Place, Glasgow G12 8TA, UK.
Tone Møller TannæsEpiGen, Medical Division, Akershus University Hospital, 1478 Lørenskog, Norway.ORCID 0000-0002-4779-2303
Kåre Inge BirkelandInstitute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
Sindre Lee-ØdegårdInstitute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.ORCID 0000-0002-0670-7555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

South Asians (SAs) have a higher risk of developing type 2 diabetes (T2D) than white Europeans, especially following gestational diabetes mellitus (GDM). Despite similar blood glucose levels post-GDM, SAs exhibit more insulin resistance (IR) than Nordics, though the underlying mechanisms are unclear. This study aimed to assess markers of adipose tissue (AT) IR and liver fat in SA and Nordic women post-GDM. A total of 179 SA and 108 Nordic women in Norway underwent oral glucose tolerance tests 1-3 years post-GDM. We measured metabolic markers and calculated the AT IR index and non-alcoholic fatty liver disease liver fat (NAFLD-LFS) scores. Results showed that normoglycaemic SAs had less non-esterified fatty acid (NEFA) suppression during the test, resembling prediabetes/T2D responses, and higher levels of plasma fetuin-A, CRP, and IL-6 but lower adiponectin, indicating AT inflammation. Furthermore, normoglycaemic SAs had higher NAFLD-LFS scores, lower insulin clearance, and higher peripheral insulin than Nordics, indicating increased AT IR, inflammation, and liver fat in SAs. Higher liver fat markers significantly contributed to the ethnic disparities in glucose metabolism, suggesting a key area for intervention to reduce T2D risk post-GDM in SAs.

Indexed as

adipose tissuefetuin-Agestational diabetesinflammationinsulin clearanceinsulin resistanceliver fatnon-esterified fatty acidspre-hepatic insulinSouth Asiantype 2 diabetes

Identifiers

PMID38786765
PMCPMC11123011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.